Blend Therapeutics Calls Up $16M

Blend Therapeutics Inc., a biopharmaceutical company based in Watertown, Mass., has raised $16 million in Series B financing. The company is backed by Flagship Ventures and New Enterprise Associates.

North AmericaUSBriefs